Literature DB >> 16445690

Hypocatalasemic fibroblasts accumulate hydrogen peroxide and display age-associated pathologies.

Christopher S Wood1, Jay I Koepke, Hua Teng, Krissy K Boucher, Sharon Katz, Patrick Chang, Laura J Terlecky, Irene Papanayotou, Paul A Walton, Stanley R Terlecky.   

Abstract

Human epidemiological studies point to an association of hypocatalasemia and an increased risk of age-related disease. Unfortunately, the cellular and molecular manifestations of hypocatalasemia are only poorly understood. In this analysis, we have extensively characterized hypocatalasemic human fibroblasts and report that they amass hydrogen peroxide and are oxidatively damaged. Protein and DNA alike are affected, as are functioning and biogenesis of peroxisomes - the subcellular organelles which normally house catalase. Despite these pathologies and their relative inability to grow, the cells do not appear to be intrinsically senescent. With the goal of restoring oxidative balance and perhaps reversing some of the accumulated damage to critical cellular components, we transduced hypocatalasemic fibroblasts with a form of catalase specifically designed to efficiently traffic to peroxisomes. We show the strategy is extremely effective, with dramatic reductions seen in cellular hydrogen peroxide levels. Future longitudinal studies aimed at examining the effects of a more continuous and long-term protein therapy may now commence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16445690     DOI: 10.1111/j.1600-0854.2005.00358.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  18 in total

1.  Peroxisomes, oxidative stress, and inflammation.

Authors:  Stanley R Terlecky; Laura J Terlecky; Courtney R Giordano
Journal:  World J Biol Chem       Date:  2012-05-26

2.  A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells.

Authors:  Courtney R Giordano; Kelly L Mueller; Laura J Terlecky; Kendra A Krentz; Aliccia Bollig-Fischer; Stanley R Terlecky; Julie L Boerner
Journal:  Exp Cell Res       Date:  2012-06-08       Impact factor: 3.905

Review 3.  Peroxisomes and aging.

Authors:  Stanley R Terlecky; Jay I Koepke; Paul A Walton
Journal:  Biochim Biophys Acta       Date:  2006-08-23

Review 4.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

5.  Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury.

Authors:  Vishnu Undyala; Stanley R Terlecky; Richard S Vander Heide
Journal:  Cardiovasc Pathol       Date:  2010-08-12       Impact factor: 2.185

Review 6.  Peroxisomes, cell senescence, and rates of aging.

Authors:  Courtney R Giordano; Stanley R Terlecky
Journal:  Biochim Biophys Acta       Date:  2012-03-29

7.  Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk.

Authors:  Oksana Ivashchenko; Paul P Van Veldhoven; Chantal Brees; Ye-Shih Ho; Stanley R Terlecky; Marc Fransen
Journal:  Mol Biol Cell       Date:  2011-03-03       Impact factor: 4.138

Review 8.  Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi; Timothy L Megraw; Jennifer Curtiss; Mahsa Shirani Faradonbeh; Pooneh Vaziri; Mohammad Hossein Nasr-Esfahani
Journal:  Neuromolecular Med       Date:  2015-11-26       Impact factor: 3.843

9.  Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease.

Authors:  Chen N Young; Jay I Koepke; Laura J Terlecky; Michael S Borkin; Savoy L Boyd; Stanley R Terlecky
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

10.  Peroxisome degradation in mammals: mechanisms of action, recent advances, and perspectives.

Authors:  Marcus Nordgren; Bo Wang; Oksana Apanasets; Marc Fransen
Journal:  Front Physiol       Date:  2013-06-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.